| Stephen Marshall Miles Hawkins, MD | |
|
13123 E 16th Ave, Box 158, Aurora, CO 80045-7106 | |
| (720) 777-1234 | |
| Not Available |
| Full Name | Stephen Marshall Miles Hawkins |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 15 Years |
| Location | 13123 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033351622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 3122 (Colorado) | Secondary |
| 2080S0012X | Pediatrics - Sleep Medicine | 3122 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Children's Hospital Colorado | Aurora, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
The Centre for Global Non-Communicable Diseases, a unique initiative that brings together researchers, policy makers, funders and patient advocacy groups worldwide to focus research and expertise on this growing global health challenge, is launched today (25 April) at the London School of Hygiene & Tropical Medicine.
Herbal Fufang – a multi-herbal preparation used in traditional Chinese medicine –increases bone mineral density and reduces fragility fractures in postmenopausal women, Chinese researchers report.
The team of researchers at Kaunas University of Technology, Lithuania are developing mathematical methods which could help diagnose breast cancer.
A surprising new theory developed at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, suggests that some bacterial cells act as "suicide bombers" in cell communities, with the altruistic intention of dying for the common good - and in the process, strengthening other cells that then become resistant to antibiotic drugs.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
› Verified 3 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
The Centre for Global Non-Communicable Diseases, a unique initiative that brings together researchers, policy makers, funders and patient advocacy groups worldwide to focus research and expertise on this growing global health challenge, is launched today (25 April) at the London School of Hygiene & Tropical Medicine.
Herbal Fufang – a multi-herbal preparation used in traditional Chinese medicine –increases bone mineral density and reduces fragility fractures in postmenopausal women, Chinese researchers report.
The team of researchers at Kaunas University of Technology, Lithuania are developing mathematical methods which could help diagnose breast cancer.
A surprising new theory developed at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, suggests that some bacterial cells act as "suicide bombers" in cell communities, with the altruistic intention of dying for the common good - and in the process, strengthening other cells that then become resistant to antibiotic drugs.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Marshall Miles Hawkins, MD Po Box 110429, Aurora, CO 80042-0429 Ph: (303) 493-7000 | Stephen Marshall Miles Hawkins, MD 13123 E 16th Ave, Box 158, Aurora, CO 80045-7106 Ph: (720) 777-1234 |
News Archive
The Centre for Global Non-Communicable Diseases, a unique initiative that brings together researchers, policy makers, funders and patient advocacy groups worldwide to focus research and expertise on this growing global health challenge, is launched today (25 April) at the London School of Hygiene & Tropical Medicine.
Herbal Fufang – a multi-herbal preparation used in traditional Chinese medicine –increases bone mineral density and reduces fragility fractures in postmenopausal women, Chinese researchers report.
The team of researchers at Kaunas University of Technology, Lithuania are developing mathematical methods which could help diagnose breast cancer.
A surprising new theory developed at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, suggests that some bacterial cells act as "suicide bombers" in cell communities, with the altruistic intention of dying for the common good - and in the process, strengthening other cells that then become resistant to antibiotic drugs.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
› Verified 3 days ago
Dr. Jonathan Orsborn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. Joel A. Friedlander, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 Fax: 720-777-7277 | |
Dr. Emily Greenwald, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Children's Hospital Colorado, Aurora, CO 80045 Phone: 720-777-1234 | |
Jessica Boat Landry, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Robert Kramer, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Richard W. Penland, Pediatrics Medicare: Medicare Enrolled Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 303-695-2628 Fax: 303-306-7753 | |
John Roger Hollister, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 |